CRO Collaboration Nexomics Biosciences operates as a contract research organization offering gene-to-structure services, presenting a clear opportunity to upsell CRO support, isotope-labeled protein production partnerships, and tailored structure-based assay development for client programs.

Protein Production With capabilities spanning recombinant protein expression, laboratory-scale fermentation, crystallization, NMR, and X-ray crystallography, there are potential sales opportunities to provide broader protein production pipelines, custom constructs, and advanced structural analysis services to biopharma researchers.

Target Discovery Nexomics aims to build IP around structure-based assay development and target characterization, suggesting cross-sell possibilities for collaboratively identifying drug targets, validating hits, and developing assay platforms for cancer, antiviral, and antibiotic programs.

Isotope Partnerships Existing collaboration with Cambridge Isotope Laboratories indicates a market-ready path for isotope-labeled proteins; sales outreach can emphasize expanding isotopic labeling services, customized labeling strategies, or co-development arrangements for complex biophysical studies.

Growth Readiness Revenue in the mid-range for a small biotech and a focus on long-term proprietary programs signal potential for early-stage funding, strategic partnerships, and pilot projects that could scale through additional services such as bioinformatics targeting, assay development, and structure-guided drug discovery initiatives.